Involvement of Multiple Signaling Pathways in Diallyl Sulfide Mediated Apoptosis in Mouse Skin Tumors

Asian Pacific Journal of Cancer Prevention

Volumn 7, Issue 4, 2006, Pages 556-562

  Kalra, Neetu ^a   Arora, Annu ^a   Shukla, Yogeshwer ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Apoptosis; DAS; Multiple signaling pathways; Ras oncoprotein; Wtp53

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ALLYL COMPOUND; ALLYL SULFIDE; ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P21; PROTEIN P53; SULFIDE;

ANIMAL; APOPTOSIS; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENZYME ACTIVATION; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; SKIN TUMOR; WESTERN BLOTTING;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ALLYL COMPOUNDS; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; ENZYME ACTIVATION; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; ONCOGENE PROTEIN P21(RAS); SIGNAL TRANSDUCTION; SKIN NEOPLASMS; SULFIDES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33947517318     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Altieri DC (2003). Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene, 22, 8581-9.
2. Antonsson B, Conti F, Ciavatta A, et al (1997). Inhibition of Bax channel-forming activity by Bcl-2. Science, 277, 370-2.
3. Arase Y, Hiwasa T, Hasegawa R, et al (2000). Prevention of v-Ha-Ras-dependent apoptosis by PDGF coordinates in phosphorylation of ERK and Akt. Biochem Biophys Res Commun, 267,33-9.
4. Arora A, Shukla Y (2002). Induction of apoptosis by diallyl sulfide in DMBA-induced mouse skin tumors. Nutr Cancer, 44, 89-94.
5. Asano T, Yao Y, Zhu J, et al (2004). The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kB and c-Myc in pancreatic cancer cells. Oncogene, 23, 8571-80.
6. Carpentier AF (2005). New therapeutic approaches in glioblastomas Bull Cancer, 92, 355-9.
7. Cengel KA, McKenna WG (2005). Molecular targets for altering radiosensitivity: Lessons from Ras as a pre-clinical and clinical model. Crit Rev Oncol Hematol, 55, 103-16.
8. Chang F, Steelman LS, Shelton JG, et al (2003). Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway. Int J Oncol, 22, 469-80.
9. de Boer JG, Yang H, Holcroft J, Skov K (2004). Chemoprotection against N-nitrosomethylbenzylamine-induced mutation in the rat esophagus. Nutr Cancer, 50, 168-73.
10. Engelbrecht AM, Gebhardt S, Louw L (2006). Ex-vivo study of MAPK profiles correlated with parameters of apoptosis during cervical carcinogenesis. Cancer Lett, 235, 93-9.
11. Garcia JF, Camacho FI, Morente M, et al (2002). Hodgkin and Reed-Sternberg Cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood, 101, 681-9.
12. Gerhauser C, Klimo K, Heiss E, et al (2003). Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat Res, 523-4, 163-72.
13. Grethe S, Porn-Ares MI (2006). p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-alpha induced endothelial apoptosis. Cell Signal, 18, 531-40.
14. Gued LR, Thomas RD, Green M (2003). Diallyl sulfide inhibits diethylstilbestrol-induced lipid peroxidation in breast tissue of female ACI rats: implications in breast cancer prevention. Oncol Rep, 10, 739-43.
15. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M (2002). Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem, 277, 3247-57.
16. Hong YS, Ham YA, Choi JH (2000). Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2, Bax, and p53 in non small cell lung cancer cell lines. Exp Mol Med, 32, 127-34.
17. Igney FH, Krammer PH (2002). Death and anti-death: tumor resistance to apoptosis. Nat Rev Cancer, 2, 277-88.
18. Illmer T, Thiede C, Fredersdorf A, et al (2005). Activation of the RAS pathway is predictive for a chemosensitive phenotype of acute myelogenous leukemia blasts. Clin Cancer Res, 11, 3217-24.
19. Jiang H, Zhang L, Koubi D, et al (2005). Roles of Ras-Erk in apoptosis of PC12 cells induced by trophic factor withdrawal or oxidative stress. J Mol Neurosci, 25,133-40.
20. Jiang H, Zhang L, Kuo J, et al (2005). Resveratrol-inducedapoptotic death in human U251 glioma cells. Mol Cancer Ther, 4, 554-61.
21. Karunagaran D, Rashmi R, Kumar TR (2005). Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets, 5, 117-29.
22. Katiyar SK, Challa A, McCormick TS, Cooper KD, Mukhtar H (1999). Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production Carcinogenesis, 20, 2117-2124.
23. Katiyar SK, Roy AM, Baliga MS (2005). Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation. Mol Cancer Ther, 4, 207-216.
24. Kirlin WG, Cai J, DeLong MJ, Patten EJ, Jones DP (1999). Dietary compounds that induce cancer preventive phase 2 enzymes activate apoptosis at comparable doses in HT29 colon carcinoma cells. J Nutr, 129, 1827-35.
25. Kirschmeier P, Bishop WR, Nielsen LL, Pickett CB, Liu S (2002). Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene, 21, 2613-22.
26. Kirschner LS (2002). Signaling pathways in adrenocortical cancer. Ann N Y Acad Sci, 968, 222-39.
27. Lens SM, Wolthuis RM, Klompmaker R, et al (2003). Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. EMBO J, 22, 2934-47.
28. Levine AJ (1997). p53, the cellular gatekeeper for growth and division. Cell, 88, 323-31.
29. Lin L, Ye Y, Zakeri Z (2005). p53, Apaf-1, caspase-3, and -9 are dispensable for Cdk5 activation during cell death. Cell Death Differ, 13, 141-50.
30. Liu Y, Zhang YM, Song DF, Cui HB (2005). Effect of apoptosis in human breast cancer cells and its probable mechanisms by genistein. Wei Sheng Yan Jiu, 34, 67-9.
31. Lowry OH, Rosenbrough NK, Farr AL (1951). Protein measurement with the Folin phenol reagent. J Biol Chem, 193, 265-75.
32. Mammas IN, Zafiropoulos A, Spandidos DA (2005). Involvement of the ras genes in female genital tract cancer. Int J Oncol, 26,1241-55.
33. Mandal M, Kim S, Younes MN, et al (2005). The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells. Br J Cancer, 92,1899-905.
34. Murphy M, Mabruk MJ, Lenane P, et al (2002). Comparison of the expression of p53, p21, Bax and the induction of apoptosis between patients with basal cell carcinoma and normal controls in response to ultraviolet irradiation. J Clin Pathol, 55, 829-33.
35. Ng SSW, Tsao MS, Chow S, Hedley DW (2000). Inhibition of p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNFalpha induced endothelial apoptosis. Cancer Res, 60, 5451-5.
36. Papoutsaki M, Moretti F, Lanza M, et al (2005). A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes. Oncogene, 24, 6970-5.
37. Pinto JT, Rivlin RS (2001). Antiproliferative effects of allium derivatives from garlic. J Nutr, 131,1058-60.
38. Poh TW, Pervaiz S (2005). LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-Akt Pathway. Cancer Res, 65, 6264-74.
39. Saleem M, Kaur S, Kweon MH, et al (2005). Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway. Carcinogenesis, 26, 1956-64.
40. Shin I, Kim S, Song H, Kim HR, Moon A (2005). H-ras-specific activation of Rac-MKK3/6-p38 pathway: Its critical role in invasion and migration of breast epithelial cells. J Biol Chem, 280, 14675-83.
41. Singh A, Arora A, Shukla Y (2004). Modulation of altered hepatic foci induction by diallyl sulphide in Wistar rats. Eur J Cancer Prev, 13, 263-9.
42. Singh A, Shukla Y (1998). Antitumour activity of diallyl sulfide on polycyclic aromatic hydrocarbon-induced mouse skin carcinogenesis. Cancer Lett, 131, 209-14.
43. Singh A, Shukla Y (1998). Antitumor activity of diallyl sulfide in two-stage mouse skin model of carcinogenesis. Biomed Environ Sci, 11, 258-63.
44. Stoklsa T, Golab J (2005). Prospects for p53-based cancer therapy. Acta Biochim Pol, 52, 321-8.
45. Stoll V, Calleja V, Vassaux G, Downward J, Lemoine NR (2005). Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer. Gut, 54, 109-16.
46. Sun SY, Hail N Jr., Lotan R (2004). Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst, 96, 662-72.
47. Szak ST, Mays D, Pietenpol JA (2001). Kinetics of p53 binding to promoter sites in vivo. Mol Cell Biol, 21, 3375-86.
48. Towbin H, Staehelin T, Gordon J (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA, 76, 4350-4.
49. Vermeulen K, Berneman ZN, Van Bockstaele DR (2003). Cell cycle and apoptosis. Cell Prolif, 36, 165-75.
50. Vogelstein B, Lane D, Levine AJ (2000). Surfing the p53 network. Nature, 408, 307-10.
51. Wada T, Pippin JW, Marshall CB, Griffin SV, Shankland SJ (2005). Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: Role of p53 and Bcl-2-Related family proteins. J Am Soc Nephrol, 16, 2615-25.
52. Waga S, Hannon GJ, Beach D, Stillman B (1994). The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature, 369, 574-78.
53. Wang W, Rastinejad F, El-Deiry WS (2003). Restoring p53-dependent tumor suppression. Cancer Biol Ther, 2, 55-63.
54. Wang XM, Chen JP, Fu WY, Xu LH (2005). Expression of P53 and Bax in rat liver induced by microcystin LR in vivo. Zhejiang Da Xue Xue Bao Yi Xue Ban, 34, 220-2.
55. Wu CC, Sheen LY, Chen HW (2001). Effects of organosulfur compounds from garlic oil on the antioxidation system in rat liver and red blood cells. Food Chem Toxicol, 39, 563-9.
56. Wu CC, Sheen LY, Chen HW (2002). Differential effects of garlic oil and its three major organosulfur components on the hepatic detoxification system in rats. J Agric Food Chem, 50, 378-83.
57. Xu L, Pathak PS, Fukumura D (2004). Hypoxia-induced activation of p38 mitogen-activated protein kinase and phosphatidylinositol 3'-kinase signaling pathways contributes to expression of interleukin 8 in human ovarian carcinoma cells. Clin Cancer Res, 10, 701-7.
58. Yan J, Yong W, Lei X, Ying Y, Jia Rui WU (2005). Differential regulation of survivin by p53 contributes to cell cycle dependent apoptosis. Cell Res, 15, 361-70.